{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:45:07Z","timestamp":1773949507581,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,19]]},"DOI":"10.7759\/cureus.105507","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:25:18Z","timestamp":1773937518000},"source":"Crossref","is-referenced-by-count":0,"title":["Platelet-Based Markers Associated With Vascular Access Dysfunction in Hemodialysis Patients"],"prefix":"10.7759","author":[{"given":"Diana D","family":"Nenova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanko G","family":"Yankov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gergana M","family":"Chausheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyuben L","family":"Stoev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.12.001","article-title":"KDOQI clinical practice guideline for vascular access: 2019 update","volume":"75","author":"Lok CE","year":"2020","unstructured":"Lok CE, Huber TS, Lee T, et al.. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020, 75:S1-S164. 10.1053\/j.ajkd.2019.12.001","journal-title":"Am J Kidney Dis"},{"key":"ref2","article-title":"Adequacy of Dialysis Treatment and the Relationship With Achieved Quality of Life and Survival in Patients With Stage V Chronic Kidney Disease","author":"Nenova D","year":"2022","unstructured":"Nenova D. Adequacy of Dialysis Treatment and the Relationship With Achieved Quality of Life and Survival in Patients With Stage V Chronic Kidney Disease. MU Varna Press, Varna, Bulgaria; 2022."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.83691","article-title":"Types of vascular access and associated clinical outcomes in dialysis patients","volume":"17","author":"Nenova DD","year":"2025","unstructured":"Nenova DD, Yankov YG. Types of vascular access and associated clinical outcomes in dialysis patients. Cureus. 2025, 17:e83691. 10.7759\/cureus.83691","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S440467","article-title":"Characteristics of vascular access cannulation complications in end stage kidney disease patients in West Java from 2018 to 2022: a retrospective observational study","volume":"17","author":"Djajakusumah TM","year":"2024","unstructured":"Djajakusumah TM, Hapsari P, Nugraha P, Muhammad A, Lukman K. Characteristics of vascular access cannulation complications in end stage kidney disease patients in West Java from 2018 to 2022: a retrospective observational study. Int J Nephrol Renovasc Dis. 2024, 17:47-58. 10.2147\/IJNRD.S440467","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15010088","article-title":"Risk factor analysis in vascular access complications for hemodialysis patients","volume":"15","author":"Ro\u015fu CD","year":"2025","unstructured":"Ro\u015fu CD, Bolintineanu SL, C\u0103p\u0103straru BF, Iacob R, Stoicescu ER, Petrea CE. Risk factor analysis in vascular access complications for hemodialysis patients. Diagnostics (Basel). 2025, 15:10.3390\/diagnostics15010088","journal-title":"Diagnostics (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s42155-020-00120-7","article-title":"Percutaneous treatment of vascular access-site complications: a ten years' experience in two centres","volume":"3","author":"Minici R","year":"2020","unstructured":"Minici R, Paone S, Talarico M, Zappia L, Abdalla K, Petull\u00e0 M, Lagan\u00e0 D. Percutaneous treatment of vascular access-site complications: a ten years' experience in two centres. CVIR Endovasc. 2020, 3:29. 10.1186\/s42155-020-00120-7","journal-title":"CVIR Endovasc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.84987","article-title":"Vascular access management for haemodialysis: a value-based approach from nephrocare experience","author":"Canaud B","year":"2019","unstructured":"Canaud B, Ponce P, Parisotto MT, Busink E, Apel C, Rammo J, Stuard S. Vascular access management for haemodialysis: a value-based approach from nephrocare experience. Vascular Access Surgery - Tips and Tricks. . IntechOpen, 2019. 1-37. 10.5772\/intechopen.84987"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn261","article-title":"Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study","volume":"23","author":"Ethier J","year":"2008","unstructured":"Ethier J, Mendelssohn DC, Elder SJ, et al.. Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2008, 23:3219-26. 10.1093\/ndt\/gfn261","journal-title":"Nephrol Dial Transplant"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/hdi.12102","article-title":"Improving arteriovenous fistula rate: effect on hemodialysis quality","volume":"18","author":"Karkar A","year":"2014","unstructured":"Karkar A, Chaballout A, Ibrahim MH, Abdelrahman M, Al Shubaili M. Improving arteriovenous fistula rate: effect on hemodialysis quality. Hemodial Int. 2014, 18:516-21. 10.1111\/hdi.12102","journal-title":"Hemodial Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/2277-9175.213666","article-title":"Comparison of complications of arteriovenous fistula with permanent catheter in hemodialysis patients: a six-month follow-up","volume":"6","author":"Momeni A","year":"2017","unstructured":"Momeni A, Mardani S, Kabiri M, Amiri M. Comparison of complications of arteriovenous fistula with permanent catheter in hemodialysis patients: a six-month follow-up. Adv Biomed Res. 2017, 6:106. 10.4103\/2277-9175.213666","journal-title":"Adv Biomed Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.11.027","article-title":"New devices and technologies for hemodialysis vascular access: a review","volume":"78","author":"Vachharajani TJ","year":"2021","unstructured":"Vachharajani TJ, Taliercio JJ, Anvari E. New devices and technologies for hemodialysis vascular access: a review\r\n. Am J Kidney Dis. 2021, 78:116-24. 10.1053\/j.ajkd.2020.11.027","journal-title":"Am J Kidney Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5455\/msm.2015.27.4-114-117","article-title":"The impact of vascular access on the adequacy of dialysis and the outcome of the dialysis treatment: one center experience","volume":"27","author":"Mutevelic A","year":"2015","unstructured":"Mutevelic A, Spanja I, Sultic-Lavic I, Koric A. The impact of vascular access on the adequacy of dialysis and the outcome of the dialysis treatment: one center experience. Mater Sociomed. 2015, 27:114-7. 10.5455\/msm.2015.27.4-114-117","journal-title":"Mater Sociomed"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2018.08.025","article-title":"Comparison of tunneled central venous catheters and native arteriovenous fistulae by evaluating the mortality and morbidity of patients with prevalent hemodialysis","volume":"118","author":"Chiu CH","year":"2019","unstructured":"Chiu CH, Wang CY, Moi SH, Wu CH, Yang CH, Chen JB. Comparison of tunneled central venous catheters and native arteriovenous fistulae by evaluating the mortality and morbidity of patients with prevalent hemodialysis. J Formos Med Assoc. 2019, 118:807-14. 10.1016\/j.jfma.2018.08.025","journal-title":"J Formos Med Assoc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5301\/jva.5000784","article-title":"Longitudinal dialysis adequacy and clinical performance of the VectorFlow hemodialysis catheter: a prospective study","volume":"18","author":"Ross JR","year":"2017","unstructured":"Ross JR, Puga TA, Philbeck TE. Longitudinal dialysis adequacy and clinical performance of the VectorFlow hemodialysis catheter: a prospective study. J Vasc Access. 2017, 18:492-7. 10.5301\/jva.5000784","journal-title":"J Vasc Access"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8050608","article-title":"Mean platelet volume predicts vascular access events in hemodialysis patients","volume":"8","author":"Lano G","year":"2019","unstructured":"Lano G, Sall\u00e9e M, Pelletier M, et al.. Mean platelet volume predicts vascular access events in hemodialysis patients. J Clin Med. 2019, 8:608. 10.3390\/jcm8050608","journal-title":"J Clin Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.6026\/973206300210783","article-title":"Mean platelet volume: a versatile biomarker in clinical diagnostics and prognostics","volume":"21","author":"Anandani G","year":"2025","unstructured":"Anandani G, Goswami P, Bhankhodia V, Dave R. Mean platelet volume: a versatile biomarker in clinical diagnostics and prognostics. Bioinformation. 2025, 21:783-8. 10.6026\/973206300210783","journal-title":"Bioinformation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.04110.x","article-title":"High platelet volume and increased risk of myocardial infarction: 39,531 participants from the general population","volume":"9","author":"Klovaite J","year":"2011","unstructured":"Klovaite J, Benn M, Yazdanyar S, Nordestgaard BG. High platelet volume and increased risk of myocardial infarction: 39,531 participants from the general population. J Thromb Haemost. 2011, 9:49-56. 10.1111\/j.1538-7836.2010.04110.x","journal-title":"J Thromb Haemost"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sft033","article-title":"Aspects of platelet disturbances in haemodialysis patients","volume":"6","author":"Schoorl M","year":"2013","unstructured":"Schoorl M, Grooteman MP, Bartels PC, Nub\u00e9 MJ. Aspects of platelet disturbances in haemodialysis patients. Clin Kidney J. 2013, 6:266-71. 10.1093\/ckj\/sft033","journal-title":"Clin Kidney J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-835678","article-title":"Platelet dysfunction in renal failure","volume":"30","author":"Boccardo P","year":"2004","unstructured":"Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semin Thromb Hemost. 2004, 30:579-89. 10.1055\/s-2004-835678","journal-title":"Semin Thromb Hemost"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2006.00179.x","article-title":"Platelet dysfunction and end-stage renal disease","volume":"19","author":"Kaw D","year":"2006","unstructured":"Kaw D, Malhotra D. Platelet dysfunction and end-stage renal disease. Semin Dial. 2006, 19:317-22. 10.1111\/j.1525-139X.2006.00179.x","journal-title":"Semin Dial"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2008.00556.x","article-title":"Treatment of bleeding in dialysis patients","volume":"22","author":"Galbusera M","year":"2009","unstructured":"Galbusera M, Remuzzi G, Boccardo P. Treatment of bleeding in dialysis patients. Semin Dial. 2009, 22:279-86. 10.1111\/j.1525-139X.2008.00556.x","journal-title":"Semin Dial"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm E","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008, 61:344-9. 10.1016\/j.jclinepi.2007.11.008","journal-title":"J Clin Epidemiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1574489","article-title":"Vascular inflammation in chronic kidney disease: the role of uremic toxins in macrophage activation","volume":"12","author":"Jha PK","year":"2025","unstructured":"Jha PK, Nakano T, Itto LY, Barbeiro MC, Lupieri A, Aikawa E, Aikawa M. Vascular inflammation in chronic kidney disease: the role of uremic toxins in macrophage activation. Front Cardiovasc Med. 2025, 12:1574489. 10.3389\/fcvm.2025.1574489","journal-title":"Front Cardiovasc Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170357","article-title":"An increase in mean platelet volume\/platelet count ratio is associated with vascular access failure in hemodialysis patients","volume":"12","author":"Shin DH","year":"2017","unstructured":"Shin DH, Rhee SY, Jeon HJ, Park JY, Kang SW, Oh J. An increase in mean platelet volume\/platelet count ratio is associated with vascular access failure in hemodialysis patients. PLoS One. 2017, 12:e0170357. 10.1371\/journal.pone.0170357","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2013.832310","article-title":"Does decreased mean platelet volume predict inflammation in chronic renal failure, dialysis, and transplanted patients?","volume":"36","author":"Bilen Y","year":"2014","unstructured":"Bilen Y, Cankaya E, Keles M, et al.. Does decreased mean platelet volume predict inflammation in chronic renal failure, dialysis, and transplanted patients?. Ren Fail. 2014, 36:69-72. 10.3109\/0886022X.2013.832310","journal-title":"Ren Fail"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6922809","article-title":"Effect of mean platelet volume to platelet count ratio on mortality in peritoneal dialysis","volume":"2022","author":"Chen J","year":"2022","unstructured":"Chen J, Zhong Z, Li J, et al.. Effect of mean platelet volume to platelet count ratio on mortality in peritoneal dialysis. Mediators Inflamm. 2022, 2022:6922809. 10.1155\/2022\/6922809","journal-title":"Mediators Inflamm"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.06.074","article-title":"Mean platelet volume and mortality risk in a national incident hemodialysis cohort","volume":"220","author":"Kim S","year":"2016","unstructured":"Kim S, Molnar MZ, Fonarow GC, et al.. Mean platelet volume and mortality risk in a national incident hemodialysis cohort. Int J Cardiol. 2016, 220:862-70. 10.1016\/j.ijcard.2016.06.074","journal-title":"Int J Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2016.03.018","article-title":"Impact of renal function on mean platelet volume and its relationship with coronary artery disease: a single-centre cohort study","volume":"141","author":"Verdoia M","year":"2016","unstructured":"Verdoia M, Barbieri L, Schaffer A, Bellomo G, Marino P, De Luca G. Impact of renal function on mean platelet volume and its relationship with coronary artery disease: a single-centre cohort study. Thromb Res. 2016, 141:139-44. 10.1016\/j.thromres.2016.03.018","journal-title":"Thromb Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1159\/000536181","article-title":"The use of anemia control model is associated with improved hemoglobin target achievement, lower rates of inappropriate erythropoietin stimulating agents, and severe anemia among dialysis patients","volume":"53","author":"Garbelli M","year":"2024","unstructured":"Garbelli M, Bellocchio F, Baro Salvador ME, et al.. The use of anemia control model is associated with improved hemoglobin target achievement, lower rates of inappropriate erythropoietin stimulating agents, and severe anemia among dialysis patients. Blood Purif. 2024, 53:405-17. 10.1159\/000536181","journal-title":"Blood Purif"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm021","article-title":"EBPG on vascular access","volume":"22 Suppl 2","author":"Tordoir J","year":"2007","unstructured":"Tordoir J, Canaud B, Haage P, et al.. EBPG on vascular access. Nephrol Dial Transplant. 2007, 22 Suppl 2:ii88-117. 10.1093\/ndt\/gfm021","journal-title":"Nephrol Dial Transplant"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.11.013","article-title":"Preemptive correction of arteriovenous access stenosis: a systematic review and meta-analysis of randomized controlled trials","volume":"67","author":"Ravani P","year":"2016","unstructured":"Ravani P, Quinn RR, Oliver MJ, et al.. Preemptive correction of arteriovenous access stenosis: a systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis. 2016, 67:446-60. 10.1053\/j.ajkd.2015.11.013","journal-title":"Am J Kidney Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/473896-platelet-based-markers-associated-with-vascular-access-dysfunction-in-hemodialysis-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:25:19Z","timestamp":1773937519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/473896-platelet-based-markers-associated-with-vascular-access-dysfunction-in-hemodialysis-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.105507","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,19]]}}}